333 related articles for article (PubMed ID: 37845689)
61. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
62. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Lazzarotto D; Tanasi I; Vitale A; Piccini M; Dargenio M; Giglio F; Forghieri F; Fracchiolla N; Cerrano M; Todisco E; Papayannidis C; Leoncin M; Defina M; Guolo F; Pasciolla C; Delia M; Chiusolo P; Mulè A; Candoni A; Bonifacio M; Pizzolo G; Foà R
Ann Hematol; 2023 May; 102(5):1099-1109. PubMed ID: 36959485
[TBL] [Abstract][Full Text] [Related]
63. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
[TBL] [Abstract][Full Text] [Related]
64. Mixed phenotype acute leukemia of T/myeloid type with a prominent cellular heterogeneity and unique karyotypic aberration 45,XY, dic(11;17).
Colovic M; Colovic N; Jankovic G; Kraguljac Kurtovic N; Vidovic A; Djordjevic V; Bogdanovic A
Int J Lab Hematol; 2012 Jun; 34(3):290-4. PubMed ID: 22212154
[TBL] [Abstract][Full Text] [Related]
65. Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
Myint HH; Tandon S; Narula G; Prasad M; Subramanian P; Patkar N; Tembhare P; Gujral S; Banavali S
J Pediatr Hematol Oncol; 2020 Oct; 42(7):415-419. PubMed ID: 32976349
[TBL] [Abstract][Full Text] [Related]
66. [Immunophenotypic Features and Clinical Prognosis of Patients with Mixed Phenotype Acute Leukemia].
Liu TQ; Huang S; Li XY; Li BX; Yao B; Zhang R; Wang Y; Liu ZQ; Hu KX; Cai B; Yu CL; Qiao JH; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1305-1310. PubMed ID: 36208227
[TBL] [Abstract][Full Text] [Related]
67. Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C.
Tibout P; Ledjiar O; Athale U; Rayar M; Kulkarni K; Truong T; Cellot S; Bittencourt H; Pelland-Marcotte MC; Tran TH
Leuk Lymphoma; 2022 Dec; 63(13):3208-3216. PubMed ID: 36067507
[TBL] [Abstract][Full Text] [Related]
68. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
69. Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult.
Huang K; Dai M; Li Q; Liu N; Lin D; Wang Q; Zhou X; Wang Z; Gao Y; Jin H; Liu X; Liu Q; Zhou H
Mediators Inflamm; 2020; 2020():8867760. PubMed ID: 33424437
[TBL] [Abstract][Full Text] [Related]
70. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
[TBL] [Abstract][Full Text] [Related]
71. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
Ratei R; Sperling C; Ludwig WD
Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
[TBL] [Abstract][Full Text] [Related]
72. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
Roberts E; Oncale M; Safah H; Schmieg J
J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
[TBL] [Abstract][Full Text] [Related]
73. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations.
Mi X; Griffin G; Lee W; Patel S; Ohgami R; Ok CY; Wang S; Geyer JT; Xiao W; Roshal M; Garcia JS; Silverman LB; Sallan SE; Aster JC; Harris MH; Weinberg OK
Am J Hematol; 2018 Nov; 93(11):1358-1367. PubMed ID: 30117174
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
75. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
76. ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia.
Tota G; Coccaro N; Zagaria A; Anelli L; Casieri P; Cellamare A; Minervini A; Minervini CF; Brunetti C; Impera L; Carluccio P; Cumbo C; Specchia G; Albano F
BMC Cancer; 2014 Dec; 14():963. PubMed ID: 25515027
[TBL] [Abstract][Full Text] [Related]
77. Immune receptor repertoires in pediatric and adult acute myeloid leukemia.
Zhang J; Hu X; Wang J; Sahu AD; Cohen D; Song L; Ouyang Z; Fan J; Wang B; Fu J; Gu S; Sade-Feldman M; Hacohen N; Li W; Ying X; Li B; Liu XS
Genome Med; 2019 Nov; 11(1):73. PubMed ID: 31771646
[TBL] [Abstract][Full Text] [Related]
78. Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
Cernan M; Szotkowski T; Pikalova Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):234-241. PubMed ID: 28422191
[TBL] [Abstract][Full Text] [Related]
79. Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia.
Ikeda M; Nakahara W; Asako M; Umeki Y; Matsuoka Y; Terakawa T; Matsunaga H; Iwasa Y; Saito R; Iwama Y; Matsui T; Oka K; Ueda S
Case Rep Hematol; 2023; 2023():3628712. PubMed ID: 36879893
[TBL] [Abstract][Full Text] [Related]
80. Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.
Ma J; Liu YC; Voss RK; Ma J; Palagani A; Caldwell E; Rosikiewicz W; Cardenas M; Foy S; Umeda M; Wilkinson MR; Inaba H; Klco JM; Rubnitz JE; Wang L
Leukemia; 2024 May; 38(5):981-990. PubMed ID: 38429501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
